Exact Mass: 550.2778

Desglucocheirotoxin

C29H42O10 (550.2778)

Convallatoxin is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a vasodilator agent and a metabolite. It is an alpha-L-rhamnoside, a 19-oxo steroid, a 14beta-hydroxy steroid, a 5beta-hydroxy steroid, a steroid lactone and a steroid aldehyde. It is functionally related to a strophanthidin. Convallatoxin is a natural product found in Crossosoma bigelovii, Convallaria keiskei, and other organisms with data available. Convallatoxin is a glycoside extracted from Convallaria majalis. Convallatoxin is also isolated from the trunk bark of Antiaris toxicaria (A15340). Convallatoxin is a constituent of Convallaria majalis. Convallaria majalis has been designated unsafe for inclusion in foods etc. by USA FDA Constituent of Convallaria majalis. Convallaria majalis has been designated unsafe for inclusion in foods etc. by USA FDA. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3]. Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3].

Hordatine A

C28H38N8O4 (550.3016)

A member of the calss of benzofurans that is a homodimer of para-coumarylagmatine where a hydroxy group of one molecule has reacted across the other molecules ethene double bond to combine the two molecules and form a furan ring.

Adonitoxin

C29H42O10 (550.2778)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

Aspecioside

C29H42O10 (550.2778)

Manumycin A

C31H38N2O7 (550.2679)

A polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. Manumycin A is a polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. It has a role as an EC 1.8.1.9 (thioredoxin reductase) inhibitor, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor, an antineoplastic agent, an apoptosis inducer, an antimicrobial agent, a bacterial metabolite, an antiatherosclerotic agent and a marine metabolite. It is a polyketide, an enamide, an epoxide, an organic heterobicyclic compound, a secondary carboxamide and a tertiary alcohol. Manumycin A is a natural product found in Streptomyces, Streptomyces griseoaurantiacus, and Streptomyces parvulus D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

Manumycin A

C31H38N2O7 (550.2679)

Fantofarone

C31H38N2O5S (550.2501)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

PA(2:0/PGF2alpha)

C25H43O11P (550.2543)

PA(2:0/PGF2alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGF2alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGF2alpha/2:0)

C25H43O11P (550.2543)

PA(PGF2alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF2alpha/2:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGE1)

C25H43O11P (550.2543)

PA(2:0/PGE1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE1/2:0)

C25H43O11P (550.2543)

PA(PGE1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE1/2:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGD1)

C25H43O11P (550.2543)

PA(2:0/PGD1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD1/2:0)

C25H43O11P (550.2543)

PA(PGD1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD1/2:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Scutalpin A

C29H42O10 (550.2778)

Plukenetione C

C33H42O7 (550.293)

14,15-Dehydroajugareptansin

C29H42O10 (550.2778)

Rescinnaminol

C32H42N2O6 (550.3043)

clerodendrin D

C29H42O10 (550.2778)

Hyperibone E

C33H42O7 (550.293)

Ajugorientin

C29H42O10 (550.2778)

Neohelmanthicin B

C29H42O10 (550.2778)

N6-Acetoxyaphelandrine

C30H38N4O6 (550.2791)

Taxinine NN 11

C33H42O7 (550.293)

12-dehydroxyghalakinoside

C29H42O10 (550.2778)

Dantaxusin B

C33H42O7 (550.293)

Tigloylseneganolide A

C32H38O8 (550.2567)

6-dehydroxyghalakinoside

C29H42O10 (550.2778)

Ajugamarin B 5

C29H42O10 (550.2778)

convallotoxoloside

C29H42O10 (550.2778)

3-epi-17beta-hydroxyafroside

C29H42O10 (550.2778)

Ajugamarin E3

C29H42O10 (550.2778)

C29H42O10

C29H42O10 (550.2778)

achicollinolide

C32H38O8 (550.2567)

3alpha-hydroxyajugamarin F4

C29H42O10 (550.2778)

tricalysionoside A

C25H42O13 (550.2625)

scutalpin H

C29H42O10 (550.2778)

securigenin-3beta-O-beta-6-deoxyguloside

C29H42O10 (550.2778)

Kabulosid

C29H42O10 (550.2778)

19-Aldehyde,3-O-beta-D-allomethyloside-(3beta,5alpha,14beta,17betaOH)-3,14,17,19-Tetrahydroxycard-20(22)-enolide

C29H42O10 (550.2778)

16-oxo-heteroclitalactone H|heteroclitalactone K

C32H38O8 (550.2567)

3beta,8beta-diangeloyloxy-5alpha,9beta-diacetoxy-4alpha-hydroxy-1beta,10alpha-epoxygermacr-11-ene

C29H42O10 (550.2778)

4beta-hydroxyafroside

C29H42O10 (550.2778)

Ajugamarin B 1

C29H42O10 (550.2778)

17-hydroxyingenol 17-benzoate-20-angelate

C32H38O8 (550.2567)

17-benzoyloxy-3-O-(2,3-dimethylbutanoyl)-20-deoxyingenol

C33H42O7 (550.293)

C25H42O13

C25H42O13 (550.2625)

C32H38O8

C32H38O8 (550.2567)

(3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol

C25H42O13 (550.2625)

stachyboside A

C29H42O10 (550.2778)

sampsonol A

C33H42O7 (550.293)

balgacyclamide b

C25H38N6O6S (550.2573)

epi-reevesioside I|reevesioside I

C29H42O10 (550.2778)

12alpha-ethoxyl-1alpha,6alpha,7beta-triacetoxy-5alpha,14beta-dihydroxy-cass-13(15)-en-16,12-olide

C29H42O10 (550.2778)

antiaroside E

C29H42O10 (550.2778)

cochinchinoid I

C33H42O7 (550.293)

cochinchinoid H

C33H42O7 (550.293)

antiaroside J

C29H42O10 (550.2778)

antiaroside O

C29H42O10 (550.2778)

artanomadimer D

C32H38O8 (550.2567)

artanomadimer B

C32H38O8 (550.2567)

1-O-cinnamoyl-17-defurano-17-oxosalannicacid methyl ester|17-defurano-17-oxoohchinin

C32H38O8 (550.2567)

Convallatoxin

C29H42O10 (550.2778)

Convallatoxin is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a vasodilator agent and a metabolite. It is an alpha-L-rhamnoside, a 19-oxo steroid, a 14beta-hydroxy steroid, a 5beta-hydroxy steroid, a steroid lactone and a steroid aldehyde. It is functionally related to a strophanthidin. Convallatoxin is a natural product found in Crossosoma bigelovii, Convallaria keiskei, and other organisms with data available. Convallatoxin is a glycoside extracted from Convallaria majalis. Convallatoxin is also isolated from the trunk bark of Antiaris toxicaria (A15340). A cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3]. Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3].

3-O-angeloyl-17-(benzoyloxy)ingenol|ingenol-3-angelate-17-benzoate

C32H38O8 (550.2567)

5-O-angeloyl-17-O-benzoylingenol

C32H38O8 (550.2567)

3beta,-angeloyloxy-5alpha,9beta-diacetoxy-4alpha-hydroxy-8beta-senecioyloxy-1beta,10alpha-epoxygermacr-11-ene

C29H42O10 (550.2778)

corotoxigenin 3beta-D-glucoside|Cortoxigenin-3-beta-D-glucosid|glucocorotoxigenin

C29H42O10 (550.2778)

22-Dehydro-12-hydroxysengosterone

C29H42O10 (550.2778)

Leu Glu Phe Glu

C26H38N4O9 (550.2639)

Lys Glu Phe Lys

C26H42N6O7 (550.3115)

Phe Lys Glu Lys

C26H42N6O7 (550.3115)

Lys Phe Glu Lys

C26H42N6O7 (550.3115)

Gln Phe Glu Lys

C25H38N6O8 (550.2751)

Lys Gln Phe Glu

C25H38N6O8 (550.2751)

Versicotide C

C28H34N6O6 (550.254)

legonoxamine F

C27H42N4O8 (550.3002)

Convallatoxin_major

C29H42O10 (550.2778)

Ala Phe Lys Trp

C29H38N6O5 (550.2904)

Ala Phe Gln Trp

C28H34N6O6 (550.254)

Ala Phe Trp Lys

C29H38N6O5 (550.2904)

Ala Phe Trp Gln

C28H34N6O6 (550.254)

Ala Lys Phe Trp

C29H38N6O5 (550.2904)

Ala Lys Trp Phe

C29H38N6O5 (550.2904)

Ala Gln Phe Trp

C28H34N6O6 (550.254)

Ala Gln Trp Phe

C28H34N6O6 (550.254)

Ala Trp Phe Lys

C29H38N6O5 (550.2904)

Ala Trp Phe Gln

C28H34N6O6 (550.254)

Ala Trp Lys Phe

C29H38N6O5 (550.2904)

Ala Trp Gln Phe

C28H34N6O6 (550.254)

Asp Phe Asn Arg

C23H34N8O8 (550.2499)

Asp Phe Arg Asn

C23H34N8O8 (550.2499)

Asp Asn Phe Arg

C23H34N8O8 (550.2499)

Asp Asn Arg Phe

C23H34N8O8 (550.2499)

Asp Arg Phe Asn

C23H34N8O8 (550.2499)

Asp Arg Asn Phe

C23H34N8O8 (550.2499)

Glu Phe Lys Lys

C26H42N6O7 (550.3115)

Glu Phe Lys Gln

C25H38N6O8 (550.2751)

Glu Phe Gln Lys

C25H38N6O8 (550.2751)

Glu Lys Phe Lys

C26H42N6O7 (550.3115)

Glu Lys Phe Gln

C25H38N6O8 (550.2751)

Glu Lys Lys Phe

C26H42N6O7 (550.3115)

Glu Lys Gln Phe

C25H38N6O8 (550.2751)

Glu Gln Phe Lys

C25H38N6O8 (550.2751)

Glu Gln Lys Phe

C25H38N6O8 (550.2751)

Phe Ala Lys Trp

C29H38N6O5 (550.2904)

Phe Ala Gln Trp

C28H34N6O6 (550.254)

Phe Ala Trp Lys

C29H38N6O5 (550.2904)

Phe Ala Trp Gln

C28H34N6O6 (550.254)

Phe Asp Asn Arg

C23H34N8O8 (550.2499)

Phe Asp Arg Asn

C23H34N8O8 (550.2499)

Phe Glu Lys Lys

C26H42N6O7 (550.3115)

Phe Glu Lys Gln

C25H38N6O8 (550.2751)

Phe Glu Gln Lys

C25H38N6O8 (550.2751)

Phe Phe His Thr

C28H34N6O6 (550.254)

Phe Phe Thr His

C28H34N6O6 (550.254)

Phe His Phe Thr

C28H34N6O6 (550.254)

Phe His Thr Phe

C28H34N6O6 (550.254)

Phe Lys Ala Trp

C29H38N6O5 (550.2904)

Phe Lys Glu Gln

C25H38N6O8 (550.2751)

Phe Lys Lys Glu

C26H42N6O7 (550.3115)

Phe Lys Gln Glu

C25H38N6O8 (550.2751)

Phe Lys Trp Ala

C29H38N6O5 (550.2904)

Phe Asn Asp Arg

C23H34N8O8 (550.2499)

Phe Asn Arg Asp

C23H34N8O8 (550.2499)

Phe Gln Ala Trp

C28H34N6O6 (550.254)

Phe Gln Glu Lys

C25H38N6O8 (550.2751)

Phe Gln Lys Glu

C25H38N6O8 (550.2751)

Phe Gln Arg Thr

C24H38N8O7 (550.2863)

Phe Gln Thr Arg

C24H38N8O7 (550.2863)

Phe Gln Trp Ala

C28H34N6O6 (550.254)

Phe Arg Asp Asn

C23H34N8O8 (550.2499)

Phe Arg Asn Asp

C23H34N8O8 (550.2499)

Phe Arg Gln Thr

C24H38N8O7 (550.2863)

Phe Arg Thr Gln

C24H38N8O7 (550.2863)

Phe Thr Phe His

C28H34N6O6 (550.254)

Phe Thr His Phe

C28H34N6O6 (550.254)

Phe Thr Gln Arg

C24H38N8O7 (550.2863)

Phe Thr Arg Gln

C24H38N8O7 (550.2863)

Phe Trp Ala Lys

C29H38N6O5 (550.2904)

Phe Trp Ala Gln

C28H34N6O6 (550.254)

Phe Trp Lys Ala

C29H38N6O5 (550.2904)

Phe Trp Gln Ala

C28H34N6O6 (550.254)

Gly Arg Arg Tyr

C23H38N10O6 (550.2976)

Gly Arg Tyr Arg

C23H38N10O6 (550.2976)

Gly Tyr Arg Arg

C23H38N10O6 (550.2976)

His Phe Phe Thr

C28H34N6O6 (550.254)

His Phe Thr Phe

C28H34N6O6 (550.254)

His Thr Phe Phe

C28H34N6O6 (550.254)

Ile Lys Gln Tyr

C26H42N6O7 (550.3115)

Ile Lys Tyr Gln

C26H42N6O7 (550.3115)

Ile Gln Lys Tyr

C26H42N6O7 (550.3115)

Ile Gln Gln Tyr

C25H38N6O8 (550.2751)

Ile Gln Tyr Lys

C26H42N6O7 (550.3115)

Ile Gln Tyr Gln

C25H38N6O8 (550.2751)

Ile Tyr Lys Gln

C26H42N6O7 (550.3115)

Ile Tyr Gln Lys

C26H42N6O7 (550.3115)

Ile Tyr Gln Gln

C25H38N6O8 (550.2751)

Lys Ala Phe Trp

C29H38N6O5 (550.2904)

Lys Ala Trp Phe

C29H38N6O5 (550.2904)

Lys Glu Phe Gln

C25H38N6O8 (550.2751)

Lys Glu Lys Phe

C26H42N6O7 (550.3115)

Lys Glu Gln Phe

C25H38N6O8 (550.2751)

Lys Phe Ala Trp

C29H38N6O5 (550.2904)

Lys Phe Glu Gln

C25H38N6O8 (550.2751)

Lys Phe Lys Glu

C26H42N6O7 (550.3115)

Lys Phe Gln Glu

C25H38N6O8 (550.2751)

Lys Phe Trp Ala

C29H38N6O5 (550.2904)

Lys Ile Gln Tyr

C26H42N6O7 (550.3115)

Lys Ile Tyr Gln

C26H42N6O7 (550.3115)

Lys Lys Glu Phe

C26H42N6O7 (550.3115)

Lys Lys Phe Glu

C26H42N6O7 (550.3115)

Lys Leu Gln Tyr

C26H42N6O7 (550.3115)

Lys Leu Tyr Gln

C26H42N6O7 (550.3115)

Lys Met Ser Trp

C25H38N6O6S (550.2573)

Lys Met Trp Ser

C25H38N6O6S (550.2573)

Lys Gln Glu Phe

C25H38N6O8 (550.2751)

Lys Gln Ile Tyr

C26H42N6O7 (550.3115)

Lys Gln Leu Tyr

C26H42N6O7 (550.3115)

Lys Gln Tyr Ile

C26H42N6O7 (550.3115)

Lys Gln Tyr Leu

C26H42N6O7 (550.3115)

Lys Ser Met Trp

C25H38N6O6S (550.2573)

Lys Ser Trp Met

C25H38N6O6S (550.2573)

Lys Trp Ala Phe

C29H38N6O5 (550.2904)

Lys Trp Phe Ala

C29H38N6O5 (550.2904)

Lys Trp Met Ser

C25H38N6O6S (550.2573)

Lys Trp Ser Met

C25H38N6O6S (550.2573)

Leu Gln Gln Tyr

C25H38N6O8 (550.2751)

Leu Gln Tyr Gln

C25H38N6O8 (550.2751)

Leu Tyr Gln Gln

C25H38N6O8 (550.2751)

Met Lys Ser Trp

C25H38N6O6S (550.2573)

Met Lys Trp Ser

C25H38N6O6S (550.2573)

Met Ser Lys Trp

C25H38N6O6S (550.2573)

Met Ser Trp Lys

C25H38N6O6S (550.2573)

Met Trp Lys Ser

C25H38N6O6S (550.2573)

Met Trp Ser Lys

C25H38N6O6S (550.2573)

Asn Asp Phe Arg

C23H34N8O8 (550.2499)

Asn Asp Arg Phe

C23H34N8O8 (550.2499)

Asn Phe Asp Arg

C23H34N8O8 (550.2499)

Asn Phe Arg Asp

C23H34N8O8 (550.2499)

Asn Arg Asp Phe

C23H34N8O8 (550.2499)

Asn Arg Phe Asp

C23H34N8O8 (550.2499)

Asn Arg Val Tyr

C24H38N8O7 (550.2863)

Asn Arg Tyr Val

C24H38N8O7 (550.2863)

Asn Val Arg Tyr

C24H38N8O7 (550.2863)

Asn Val Tyr Arg

C24H38N8O7 (550.2863)

Asn Tyr Arg Val

C24H38N8O7 (550.2863)

Asn Tyr Val Arg

C24H38N8O7 (550.2863)

Gln Ala Phe Trp

C28H34N6O6 (550.254)

Gln Ala Trp Phe

C28H34N6O6 (550.254)

Gln Glu Phe Lys

C25H38N6O8 (550.2751)

Gln Glu Lys Phe

C25H38N6O8 (550.2751)

Gln Phe Ala Trp

C28H34N6O6 (550.254)

Gln Phe Lys Glu

C25H38N6O8 (550.2751)

Gln Phe Arg Thr

C24H38N8O7 (550.2863)

Gln Phe Thr Arg

C24H38N8O7 (550.2863)

Gln Phe Trp Ala

C28H34N6O6 (550.254)

Gln Ile Gln Tyr

C25H38N6O8 (550.2751)

Gln Ile Tyr Gln

C25H38N6O8 (550.2751)

Gln Lys Glu Phe

C25H38N6O8 (550.2751)

Gln Lys Phe Glu

C25H38N6O8 (550.2751)

Gln Leu Gln Tyr

C25H38N6O8 (550.2751)

Gln Leu Tyr Gln

C25H38N6O8 (550.2751)

Gln Gln Ile Tyr

C25H38N6O8 (550.2751)

Gln Gln Leu Tyr

C25H38N6O8 (550.2751)

Gln Gln Tyr Ile

C25H38N6O8 (550.2751)

Gln Gln Tyr Leu

C25H38N6O8 (550.2751)

Gln Arg Phe Thr

C24H38N8O7 (550.2863)

Gln Arg Thr Phe

C24H38N8O7 (550.2863)

Gln Thr Phe Arg

C24H38N8O7 (550.2863)

Gln Thr Arg Phe

C24H38N8O7 (550.2863)

Gln Trp Ala Phe

C28H34N6O6 (550.254)

Gln Trp Phe Ala

C28H34N6O6 (550.254)

Gln Tyr Ile Gln

C25H38N6O8 (550.2751)

Gln Tyr Leu Gln

C25H38N6O8 (550.2751)

Gln Tyr Gln Ile

C25H38N6O8 (550.2751)

Gln Tyr Gln Leu

C25H38N6O8 (550.2751)

Arg Asp Phe Asn

C23H34N8O8 (550.2499)

Arg Asp Asn Phe

C23H34N8O8 (550.2499)

Arg Phe Asp Asn

C23H34N8O8 (550.2499)

Arg Phe Asn Asp

C23H34N8O8 (550.2499)

Arg Phe Gln Thr

C24H38N8O7 (550.2863)

Arg Phe Thr Gln

C24H38N8O7 (550.2863)

Arg Gly Arg Tyr

C23H38N10O6 (550.2976)

Arg Gly Tyr Arg

C23H38N10O6 (550.2976)

Arg Asn Asp Phe

C23H34N8O8 (550.2499)

Arg Asn Phe Asp

C23H34N8O8 (550.2499)

Arg Asn Val Tyr

C24H38N8O7 (550.2863)

Arg Asn Tyr Val

C24H38N8O7 (550.2863)

Arg Gln Phe Thr

C24H38N8O7 (550.2863)

Arg Gln Thr Phe

C24H38N8O7 (550.2863)

Arg Arg Gly Tyr

C23H38N10O6 (550.2976)

Arg Arg Tyr Gly

C23H38N10O6 (550.2976)

Arg Thr Phe Gln

C24H38N8O7 (550.2863)

Arg Thr Gln Phe

C24H38N8O7 (550.2863)

Arg Val Asn Tyr

C24H38N8O7 (550.2863)

Arg Val Tyr Asn

C24H38N8O7 (550.2863)

Arg Tyr Gly Arg

C23H38N10O6 (550.2976)

Arg Tyr Asn Val

C24H38N8O7 (550.2863)

Arg Tyr Arg Gly

C23H38N10O6 (550.2976)

Arg Tyr Val Asn

C24H38N8O7 (550.2863)

Ser Lys Met Trp

C25H38N6O6S (550.2573)

Ser Lys Trp Met

C25H38N6O6S (550.2573)

Ser Met Lys Trp

C25H38N6O6S (550.2573)

Ser Met Trp Lys

C25H38N6O6S (550.2573)

Ser Trp Lys Met

C25H38N6O6S (550.2573)

Ser Trp Met Lys

C25H38N6O6S (550.2573)

Thr Phe Phe His

C28H34N6O6 (550.254)

Thr Phe His Phe

C28H34N6O6 (550.254)

Thr Phe Gln Arg

C24H38N8O7 (550.2863)

Thr Phe Arg Gln

C24H38N8O7 (550.2863)

Thr His Phe Phe

C28H34N6O6 (550.254)

Thr Gln Phe Arg

C24H38N8O7 (550.2863)

Thr Gln Arg Phe

C24H38N8O7 (550.2863)

Thr Arg Phe Gln

C24H38N8O7 (550.2863)

Thr Arg Gln Phe

C24H38N8O7 (550.2863)

Val Asn Arg Tyr

C24H38N8O7 (550.2863)

Val Asn Tyr Arg

C24H38N8O7 (550.2863)

Val Arg Asn Tyr

C24H38N8O7 (550.2863)

Val Arg Tyr Asn

C24H38N8O7 (550.2863)

Val Tyr Asn Arg

C24H38N8O7 (550.2863)

Val Tyr Arg Asn

C24H38N8O7 (550.2863)

Trp Ala Phe Lys

C29H38N6O5 (550.2904)

Trp Ala Phe Gln

C28H34N6O6 (550.254)

Trp Ala Lys Phe

C29H38N6O5 (550.2904)

Trp Ala Gln Phe

C28H34N6O6 (550.254)

Trp Phe Ala Lys

C29H38N6O5 (550.2904)

Trp Phe Ala Gln

C28H34N6O6 (550.254)

Trp Phe Lys Ala

C29H38N6O5 (550.2904)

Trp Phe Gln Ala

C28H34N6O6 (550.254)

Trp Lys Ala Phe

C29H38N6O5 (550.2904)

Trp Lys Phe Ala

C29H38N6O5 (550.2904)

Trp Lys Met Ser

C25H38N6O6S (550.2573)

Trp Lys Ser Met

C25H38N6O6S (550.2573)

Trp Met Lys Ser

C25H38N6O6S (550.2573)

Trp Met Ser Lys

C25H38N6O6S (550.2573)

Trp Gln Ala Phe

C28H34N6O6 (550.254)

Trp Gln Phe Ala

C28H34N6O6 (550.254)

Trp Ser Lys Met

C25H38N6O6S (550.2573)

Trp Ser Met Lys

C25H38N6O6S (550.2573)

Tyr Gly Arg Arg

C23H38N10O6 (550.2976)

Tyr Ile Gln Gln

C25H38N6O8 (550.2751)

Tyr Leu Gln Gln

C25H38N6O8 (550.2751)

Tyr Asn Arg Val

C24H38N8O7 (550.2863)

Tyr Asn Val Arg

C24H38N8O7 (550.2863)

Tyr Gln Ile Gln

C25H38N6O8 (550.2751)

Tyr Gln Leu Gln

C25H38N6O8 (550.2751)

Tyr Gln Gln Ile

C25H38N6O8 (550.2751)

Tyr Gln Gln Leu

C25H38N6O8 (550.2751)

Tyr Arg Gly Arg

C23H38N10O6 (550.2976)

Tyr Arg Asn Val

C24H38N8O7 (550.2863)

Tyr Arg Arg Gly

C23H38N10O6 (550.2976)

Tyr Arg Val Asn

C24H38N8O7 (550.2863)

Tyr Val Asn Arg

C24H38N8O7 (550.2863)

Tyr Val Arg Asn

C24H38N8O7 (550.2863)

PHOHA-PA

C26H47O10P (550.2907)

OG-PA

C26H47O10P (550.2907)

Antiaroside C

C29H42O10 (550.2778)

2,5-bis(tert-dodecyldithio)-1,3,4-thiadiazole

C26H50N2S5 (550.2577)

lead(II) isodecanoate

C20H38O4Pb (550.2536)

lead ii neodecanoate

C20H38O4Pb (550.2536)

benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid

C25H42O13 (550.2625)

R-3,3-Bis(4-(1,1-dimethylethyl)phenyl)-1,1-bi-2-naphthol

C40H38O2 (550.2872)

(S)-4-(2-amino-3-((2-aminoethyl)amino)propyl)phenol hydrochloride

C28H40F2N4O3S (550.2789)

Mesopryopheophorbide a methyl ester

C34H38N4O3 (550.2944)

L-leucyl-arginomycin

C24H40N9O6+ (550.3101)

N-[4-(diaminomethylideneamino)butyl]-5-[(E)-3-[4-(diaminomethylideneamino)butylamino]-3-oxoprop-1-enyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-carboxamide

C28H38N8O4 (550.3016)

Tobramycin 2-phosphate

C18H41N5O12P+3 (550.2489)

[(4S)-4-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-3-methyl-5-oxopentyl]-(diaminomethylidene)-methylazanium

C24H40N9O6+ (550.3101)

Manumycin A

C31H38N2O7 (550.2679)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

PA(2:0/PGF2alpha)

C25H43O11P (550.2543)

PA(PGF2alpha/2:0)

C25H43O11P (550.2543)

PA(2:0/PGE1)

C25H43O11P (550.2543)

PA(PGE1/2:0)

C25H43O11P (550.2543)

PA(2:0/PGD1)

C25H43O11P (550.2543)

PA(PGD1/2:0)

C25H43O11P (550.2543)

8-Methyl-8-desvinylprotoporphyrin

C33H34N4O4 (550.258)

Ajugapitin

C29H42O10 (550.2778)

A diterpenoid isolated from the aerial parts of Ajuga bracteosa and has been shown to exhibit antifeedant activity against Spodoptera littoralis.

Chisomicine A

C32H38O8 (550.2567)

A natural product found in Chisocheton ceramicus.

Ajugamarin B1

C29H42O10 (550.2778)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

(R)-2,4,6-Trimethyl-deca-2,4-dienoic acid {(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-6-(2-hydroxy-5-oxo-cyclopent-1-enylcarbamoyl)-hexa-1,3,5-trienyl]-2-oxo-7-oxa-bicyclo[4.1.0]hept-3-en-3-yl}-amide

C31H38N2O7 (550.2679)

2-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(5-phenyl-3-isoxazolyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C30H38N4O6 (550.2791)

(2E,4E,6R)-N-[(5S,6R)-5-[(1E,3E,5E)-7-[(2,5-dioxocyclopentyl)amino]-7-oxohepta-1,3,5-trienyl]-5-hydroxy-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide

C31H38N2O7 (550.2679)

2-[(2S,3R,4S,5R)-5-[[4-[[benzyl(methyl)amino]methyl]triazol-1-yl]methyl]-3,4-dihydroxyoxolan-2-yl]-1-[4-(2-methoxyphenyl)piperazin-1-yl]ethanone

C29H38N6O5 (550.2904)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C26H47O10P (550.2907)

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C29H43O8P (550.2695)

Desglucocheirotoxin

C29H42O10 (550.2778)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins

1-(9Z-octadecenoyl)-2-glutaryl-sn-glycero-3-phosphate

C26H47O10P (550.2907)

SQMG 16:3

C25H42O11S (550.2448)

PA O-16:0/7:3;O3

C26H47O10P (550.2907)

PA O-23:3;O3

C26H47O10P (550.2907)

PA P-16:0/7:2;O3

C26H47O10P (550.2907)

PA 14:0/8:3;O3

C25H43O11P (550.2543)

PA 14:1/8:2;O3

C25H43O11P (550.2543)

PA 14:1/9:1;O2

C26H47O10P (550.2907)

PA 16:0/7:2;O2

C26H47O10P (550.2907)

PA 18:1/5:1;O2

C26H47O10P (550.2907)

PA 22:3;O3

C25H43O11P (550.2543)

PA 22:6/4:1

C29H43O8P (550.2695)

PA 26:7

C29H43O8P (550.2695)

LPGP O-16:0

C22H48O11P2 (550.2672)

PG O-20:3;O

C26H47O10P (550.2907)

PG P-16:1/4:1;O

C26H47O10P (550.2907)

LPG 20:3;O

C26H47O10P (550.2907)

PG 16:1/4:1

C26H47O10P (550.2907)

PG 18:2/2:0

C26H47O10P (550.2907)

PG 2:0_18:2

C26H47O10P (550.2907)

PG 20:2

C26H47O10P (550.2907)

LPEth 25:7

C30H47O7P (550.3059)

LPM 26:7

C30H47O7P (550.3059)

PM 25:7

C29H43O8P (550.2695)

ST 23:3;O4;GlcA

C29H42O10 (550.2778)

ST 27:7;O;GlcA

C33H42O7 (550.293)

ST 19:0;O8;Hex

C25H42O13 (550.2625)

ST 23:4;O5;Hex

C29H42O10 (550.2778)

ST 25:1;O8;S

C25H42O11S (550.2448)

ST 26:0;O7;S

C26H46O10S (550.2812)

ST 29:5;O5;S

C29H42O8S (550.26)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2r)-2-methylbutanoate

C29H42O10 (550.2778)

(9ar,11as)-1-{2-hydroxy-1-[5-(methoxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthrene-7-sulfonic acid

C29H42O8S (550.26)

5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl 2-methylbutanoate

C29H42O10 (550.2778)

methyl (2s,3r,5r)-2-{[(1r,3as,3br,5as,7r,8r,9ar,9bs,11ar)-3a,8,9a-trihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-5-methyloxolane-3-carboxylate

C29H42O10 (550.2778)

(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

5a,10-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(9r,13s,16s,17r,18s)-16-[(1r)-1-hydroxy-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate

C32H38O8 (550.2567)

2,4-dimethyl-4-[2-(2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl)ethenyl]cyclohexyl 3-methyl-2-(methylamino)butanoate

C32H42N2O6 (550.3043)

n-[(1ar,2s,6as,6bs)-5-{1-[(1ar,2s,6as,6bs)-4-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-5-yl]ethyl}-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

C30H38N4O6 (550.2791)

4-(3-{3a,5a,7,8,11-pentahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-3-hydroxy-2-oxobutyl)-3,5-dimethyloxolan-2-one

C29H42O10 (550.2778)

(2e,4e,6r)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

2-{[(1-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-3-hydroxypropanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C27H42N4O8 (550.3002)

3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadeca-9,11-dien-14-yl (2z)-2-methylbut-2-enoate

C32H38O8 (550.2567)

9α,10β-diacetoxy-5α-cinnamoyloxytaxa-4(20),11-dien-13α-ol

C33H42O7 (550.293)

{"Ingredient_id": "HBIN014037","Ingredient_name": "9\u03b1,10\u03b2-diacetoxy-5\u03b1-cinnamoyloxytaxa-4(20),11-dien-13\u03b1-ol","Alias": "NA","Ingredient_formula": "C33H42O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5288","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate

C32H38O8 (550.2567)

(1r,3r,5s,8r,9r,10r,13s)-5,13-bis(acetyloxy)-10-hydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-9-yl (2e)-3-phenylprop-2-enoate

C33H42O7 (550.293)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-{hexahydrofuro[2,3-b]furan-2-yl}-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbut-2-enoate

C29H42O10 (550.2778)

(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3r,7s,9s,11r)-11-benzoyl-3-(2-hydroxypropan-2-yl)-6,6,10,10-tetramethyl-13-(3-methylbut-2-en-1-yl)-4,5-dioxatetracyclo[9.3.1.1⁹,¹³.0¹,⁷]hexadecane-12,14,15-trione

C33H42O7 (550.293)

(1r,3as,3br,5as,7r,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,2s,4r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

5,9-bis(acetyloxy)-4-hydroxy-4,10-dimethyl-8-[(3-methylbut-2-enoyl)oxy]-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl 2-methylbut-2-enoate

C29H42O10 (550.2778)

(1r,3as,3br,5as,7r,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1s,3ar,3bs,5as,7s,9as,9bs,10r,11as)-5a,10-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,2s,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl (2r)-2-methylbutanoate

C29H42O10 (550.2778)

24-hydroxy-17-(4-hydroxyphenyl)-19-oxo-16-oxa-1,6,10,23-tetraazatetracyclo[9.8.6.2¹²,¹⁵.0¹⁴,¹⁸]heptacosa-12(27),13,15(26),23-tetraen-6-yl acetate

C30H38N4O6 (550.2791)

(1r,2r,3as,3br,5ar,7s,9ar,9bs,11ar)-2,3a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C29H42O10 (550.2778)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylbutanoate

C29H42O10 (550.2778)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylbutanoate

C29H42O10 (550.2778)

5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbutanoate

C29H42O10 (550.2778)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbutanoate

C29H42O10 (550.2778)

4-[(1s,3r,5s,7r,9r,10s,12r,14r,17r,18s,19r,22s)-9,10,17,22-tetrahydroxy-14-(hydroxymethyl)-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(3s,4s,5r)-4-[(3r)-3-[(1s,3ar,5as,7r,8s,9ar,9br,11r,11as)-3a,5a,7,8,11-pentahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-3-hydroxy-2-oxobutyl]-3,5-dimethyloxolan-2-one

C29H42O10 (550.2778)

[(1s,4s,5s,6r,9s,10r,11r,12r,14r)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,14-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C32H38O8 (550.2567)

(2s)-2-methyl-1-[9,12,14-trihydroxy-13-(2-hydroxy-3-methylbut-3-en-1-yl)-5,5-dimethyl-8-[(2s)-2-methylbutanoyl]-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaen-15-yl]butan-1-one

C32H38O8 (550.2567)

(1r,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3r,5s,8r,9r,10r,13s)-10,13-bis(acetyloxy)-9-hydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl (2e)-3-phenylprop-2-enoate

C33H42O7 (550.293)

methyl 2-{[3a,8,9a-trihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-5-methyloxolane-3-carboxylate

C29H42O10 (550.2778)

(4s,7s,18s,21s)-3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione

C28H34N6O6 (550.254)

(11r,17s,18s)-24-hydroxy-17-(4-hydroxyphenyl)-19-oxo-16-oxa-1,6,10,23-tetraazatetracyclo[9.8.6.2¹²,¹⁵.0¹⁴,¹⁸]heptacosa-12(27),13,15(26),23-tetraen-6-yl acetate

C30H38N4O6 (550.2791)

(1r,3r,7s,9s,11r,13r)-11-benzoyl-3-(2-hydroxypropan-2-yl)-6,6,10,10-tetramethyl-13-(3-methylbut-2-en-1-yl)-4,5-dioxatetracyclo[9.3.1.1⁹,¹³.0¹,⁷]hexadecane-12,14,15-trione

C33H42O7 (550.293)

(4r)-3-(hydroxymethyl)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one

C25H42O13 (550.2625)

4-[(1s,3r,5s,7s,9r,10s,12r,14r,15s,18r,19r,22s,23r)-9,10,22-trihydroxy-7,14-bis(hydroxymethyl)-18-methyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

[(1s,4s,5r,6r,9s,10r,11r,12r,14r)-4,5,6-trihydroxy-3,11,14-trimethyl-7-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C32H38O8 (550.2567)

(1r,3r,7r,9s,11r,13s)-11-benzoyl-3-(2-hydroxypropan-2-yl)-6,6,10,10-tetramethyl-13-(3-methylbut-2-en-1-yl)-4,5-dioxatetracyclo[9.3.1.1⁹,¹³.0¹,⁷]hexadecane-12,14,15-trione

C33H42O7 (550.293)

(1r,3as,3br,5ar,7s,9ar,9bs,11r,11as)-3a,11-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1s,4r,11r,14s,17s,20r)-4-[(2s)-butan-2-yl]-14-[(1r)-1-hydroxyethyl]-17-isopropyl-11,20-dimethyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol

C25H38N6O6S (550.2573)

(1r,3as,3br,5ar,7s,9ar,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

1-({6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraen-17-yl}oxy)-3-(3,4,5-trimethoxyphenyl)propan-1-ol

C32H42N2O6 (550.3043)

(1r,3r,8s,10s)-8-benzoyl-10-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-6-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-3-(2-hydroxypropan-2-yl)-9,9-dimethyl-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C33H42O7 (550.293)

(1r,2s,4r)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexyl (2s)-3-methyl-2-(methylamino)butanoate

C32H42N2O6 (550.3043)

4-[(1r,3s,5s,7s,10s,11r,13r,14s,15r,18r)-13,18-dihydroxy-10,14-dimethyl-7-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C29H42O10 (550.2778)

4-hydroxy-3,5,5-trimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(1r,3as,3br,5as,7s,9as,9bs,11r,11as)-7-{[(2s,3r,4r,6r)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3a,5a,11-trihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3as,3bs,5ar,7s,9ar,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3as,3br,5as,7r,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

n-[5-(1-{4-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-5-yl}ethyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

C30H38N4O6 (550.2791)

(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

2-(hydroxymethyl)-6-{[1,5,5-trimethyl-6-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol

C25H42O13 (550.2625)

(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,2s,4r,4ar,5s,6r,8s,8ar)-5-[(2r,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2r)-2-methylbutanoate

C29H42O10 (550.2778)

4,6'-dihydroxy-2',5',5',8'a-tetramethyl-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalene]-7-carbaldehyde

C29H42O10 (550.2778)

3-hydroxy-4-{[1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-[(2-methylbut-2-enoyl)oxy]propan-2-yl]oxy}-3-methyl-4-oxobutan-2-yl octanoate

C29H42O10 (550.2778)

5,9-bis(acetyloxy)-4-hydroxy-4,10-dimethyl-8-[(2-methylbut-2-enoyl)oxy]-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl 2-methylbut-2-enoate

C29H42O10 (550.2778)

5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylbutanoate

C29H42O10 (550.2778)

(11s,17s,18s)-24-hydroxy-17-(4-hydroxyphenyl)-19-oxo-16-oxa-1,6,10,23-tetraazatetracyclo[9.8.6.2¹²,¹⁵.0¹⁴,¹⁸]heptacosa-12(27),13,15(26),23-tetraen-6-yl acetate

C30H38N4O6 (550.2791)

(1r,3as,5as,7s,9as,11ar)-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,5s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione

C28H34N6O6 (550.254)

(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C29H42O10 (550.2778)

4-[9,10,17,22-tetrahydroxy-14-(hydroxymethyl)-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

(1s)-2-[(4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

5-[(1s,3r,5s,7s,9r,10s,12r,14r,15s,18r,19s,22s,23r)-9,10,22-trihydroxy-7,14-bis(hydroxymethyl)-18-methyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-2h-furan-3-one

C29H42O10 (550.2778)

4-{13,18-dihydroxy-10,14-dimethyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl}-5h-furan-2-one

C29H42O10 (550.2778)

{4-[(2,3-dimethylbutanoyl)oxy]-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl}methyl benzoate

C33H42O7 (550.293)

3a,10-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

(1r,3s,4s,5r,7r,8s,9s,10r)-5,9-bis(acetyloxy)-4-hydroxy-4,10-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl (2z)-2-methylbut-2-enoate

C29H42O10 (550.2778)

4-[(1s,3r,5s,7r,9r,10s,12r,14r,15s,17r,18s,19r,22r,23r)-9,10,17,22-tetrahydroxy-14-(hydroxymethyl)-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

11-benzoyl-3-(2-hydroxypropan-2-yl)-6,6,10,10-tetramethyl-13-(3-methylbut-2-en-1-yl)-4,5-dioxatetracyclo[9.3.1.1⁹,¹³.0¹,⁷]hexadecane-12,14,15-trione

C33H42O7 (550.293)

8-benzoyl-10-(3-hydroxy-3-methylbut-1-en-1-yl)-6-(2-hydroxy-3-methylbut-3-en-1-yl)-3-(2-hydroxypropan-2-yl)-9,9-dimethyl-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C33H42O7 (550.293)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,3s,6s)-1,5,5-trimethyl-6-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol

C25H42O13 (550.2625)

(1r,2s,4r,4ar,5s,6r,8s,8ar)-5-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C29H42O10 (550.2778)

[(1s,4s,5s,6r,9s,10r,11r,12r,14r)-4-{[(2r)-2,3-dimethylbutanoyl]oxy}-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C33H42O7 (550.293)

4-[(1s,3r,5s,7r,9r,10s,12r,14r,15s,17r,18s,19r,22s,23r)-9,10,17,22-tetrahydroxy-14-(hydroxymethyl)-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

4-[(1s,3r,5s,7s,9r,10s,12r,14r,15s,18r,19r,22r,23r)-9,10,22-trihydroxy-7,14-bis(hydroxymethyl)-18-methyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

(2r,3's,4'ar,5'r,6'r,6'ar,10'ar,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

12,14-bis(acetyloxy)-3-(1-methoxy-1-oxopropan-2-yl)-7,11,15-trimethyl-2-oxo-4-oxatricyclo[9.4.0.0³,⁵]pentadec-6-en-10-yl butanoate

C29H42O10 (550.2778)

(4,5,6-trihydroxy-3,11,14-trimethyl-7-{[(2-methylbut-2-enoyl)oxy]methyl}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl)methyl benzoate

C32H38O8 (550.2567)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

(1r,4ar,5s,6s,8s,8ar)-5-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl 2-methylbutanoate

C29H42O10 (550.2778)

(1r,3s,4s,5r,7r,8s,9s,10r)-5,9-bis(acetyloxy)-4-hydroxy-4,10-dimethyl-8-[(3-methylbut-2-enoyl)oxy]-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl (2z)-2-methylbut-2-enoate

C29H42O10 (550.2778)

(2r,3's,4'ar,5'r,6's,6'ar,10'as,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

(1r,3as,3br,5ar,7s,9ar,9bs,11r,11as)-3a,11-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

4-[9,10,22-trihydroxy-7,14-bis(hydroxymethyl)-18-methyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-19-yl]-5h-furan-2-one

C29H42O10 (550.2778)

16-[1-hydroxy-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate

C32H38O8 (550.2567)

(1's,3r,3's,3as,6's,7'r,8's,9as,9bs,10'r,12's)-10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate

C32H38O8 (550.2567)

(1r,3s,7s,9s,11r,13s)-11-benzoyl-3-(2-hydroxypropan-2-yl)-6,6,10,10-tetramethyl-13-(3-methylbut-2-en-1-yl)-4,5-dioxatetracyclo[9.3.1.1⁹,¹³.0¹,⁷]hexadecane-12,14,15-trione

C33H42O7 (550.293)

14-(1-hydroxyethyl)-17-isopropyl-11,20-dimethyl-4-(sec-butyl)-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol

C25H38N6O6S (550.2573)

(1r,3r,5s,6z,10s,11r,12r,14s,15r)-12,14-bis(acetyloxy)-3-[(2s)-1-methoxy-1-oxopropan-2-yl]-7,11,15-trimethyl-2-oxo-4-oxatricyclo[9.4.0.0³,⁵]pentadec-6-en-10-yl butanoate

C29H42O10 (550.2778)

(1s)-2-[(1r,2r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2r)-2-methylbutanoate

C29H42O10 (550.2778)

(1r,2r,4r)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexyl (2s)-3-methyl-2-(methylamino)butanoate

C32H42N2O6 (550.3043)

3-(hydroxymethyl)-5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(4s)-4-hydroxy-3,5,5-trimethyl-4-[(3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one

C25H42O13 (550.2625)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-5-[(2s)-2-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8a-(hydroxymethyl)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2s)-2-methylbutanoate

C29H42O10 (550.2778)

(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H42O13 (550.2625)

(1r,2s,3as,3br,5ar,7s,9ar,9bs,11ar)-2,3a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C29H42O10 (550.2778)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbutanoate

C29H42O10 (550.2778)

(2e,4e,6r)-n-[(1s,5r,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

(2r,2'r,4'as,6'r,8'as)-4,6'-dihydroxy-2',5',5',8'a-tetramethyl-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalene]-7-carbaldehyde

C29H42O10 (550.2778)

n-[(1r,5s,6r)-5-hydroxy-5-{6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid

C31H38N2O7 (550.2679)

3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C29H42O10 (550.2778)

(2s,3r)-3-hydroxy-4-{[(1r,2s)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-{[(2z)-2-methylbut-2-enoyl]oxy}propan-2-yl]oxy}-3-methyl-4-oxobutan-2-yl octanoate

C29H42O10 (550.2778)

(2r,3r,4s,5s,7s,9r,12s,14s)-2,3,14-tris(acetyloxy)-7,12-dihydroxy-4,15,16,16-tetramethyl-8-methylidenetricyclo[10.3.1.0⁴,⁹]hexadec-1(15)-en-5-yl acetate

C29H42O10 (550.2778)

8-(acetyloxy)-5-[2-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8a-(hydroxymethyl)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbutanoate

C29H42O10 (550.2778)

(1r,2s,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl (2s)-2-methylbutanoate

C29H42O10 (550.2778)